Skip to main navigation Skip to search Skip to main content

Activation of Raf1 and the ERK pathway in response to L-ascorbic acid in acute myeloid leukemia cells

  • Yonsei University
  • Center for the Improvement of Human Functioning International
  • University of Kansas

Research output: Contribution to journalArticlepeer-review

Abstract

L-ascorbic acid (LAA) shows cytotoxicity and induces apoptosis of malignant cells in vitro, but the mechanisms by which such effects occur have not been elucidated. In the present study, we provide evidence that the ERK MAP kinase pathway is activated in response to LAA (< 1 mM) in acute myeloid leukemia cell lines. LAA treatment of cells induces a dose-dependent phosphorylation of extracellular signal-regulated kinases (ERK) and results in activation of its catalytic domain. Our data also demonstrate that the small G protein Raf1 and MAPK-activated protein kinase 2 are activated by LAA as an upstream and a downstream regulator of ERK, respectively. Although the ERK pathway has been known to activate cell proliferation, pharmacologic inhibition of ERK reduces LAA-dependent apoptosis and growth inhibitory response of acute myeloid leukemia cell lines, suggesting that this signaling cascade positively regulates induction of apoptotic response by LAA.

Original languageEnglish
Pages (from-to)111-119
Number of pages9
JournalCellular Signalling
Volume17
Issue number1
DOIs
StatePublished - Jan 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute myeloid leukemia
  • Dominant negative ERK1
  • ERK
  • L-ascorbic acid
  • MAPKAP kinase 2
  • Raf1

Fingerprint

Dive into the research topics of 'Activation of Raf1 and the ERK pathway in response to L-ascorbic acid in acute myeloid leukemia cells'. Together they form a unique fingerprint.

Cite this